ArticleBMC microbiology2025
Genomic insights into multidrug resistant Escherichia coli from bovine mastitis in Bangladesh.
Article in BMC microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Draft genome sequence ofMicrobiology resource announcements · 2026Article
- Whole-genome sequence data of a multidrug-resistantData in brief · 2026Article
- Bacteriocins in Veterinary Medicine: From Antibiotic Limitations to Targeted Solutions.International journal of molecular sciences · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundMastitis poses a significant threat to dairy industry and public health due to the emergence of multidrug-resistant (MDR) Escherichia coli. This study provides a genomic characterization of two MDR E. coli strains, MBBL4 and MBBL5, from bovine mastitis in Bangladesh, highlighting their evolutionary relationships, resistome, and virulome.
methodsSpecies-level identification of MBBL4 and MBBL5 was confirmed using biochemical assays, VITEK-2 system, and 16S rRNA gene sequencing. Antimicrobial susceptibility profiling was conducted to determine their resistance patterns. Whole genome sequencing (WGS) and comprehensive genomic analysis were performed for phylogenetic, comparative genomics, mobile genetic elements (MGEs), antimicrobial resistance genes (ARGs), and virulence factor genes (VFGs) analyses.
resultsBoth isolates exhibited extensive MDR patterns, showing resistance to ten antibiotics. Phylogenetic and ANI analyses showed that MBBL4 clustered with mastitis-associated and human bacteremia strains of E. coli, while MBBL5 was closely related to wildlife-associated strains, reflecting divergent evolutionary lineages. Pangenome analysis revealed an open pangenome structure, indicating high genetic diversity, with MBBL4 harboring 21 unique genes and MBBL5 possessing nine unique genes. Both genomes harbored numerous ARGs spanning over 11 antibiotic classes, and VFGs, predominantly associated with adherence and secretion systems, underscoring their extensive resistome, virulome, and adaptive potentials. Abundant MGEs (plasmids, prophages, insertion sequence elements and genomic islands) further underscored the role of horizontal gene transfer in driving resistance and virulence in these strains.
conclusionThis study highlights the zoonotic potential and adaptive capacity of MDR E. coli from bovine mastitis in Bangladesh driven by resistome, virulome, and mobile genetic elements. These findings highlight the urgent need for One Health-based genomic surveillance to mitigate MDR E. coli transmission from dairy farms to humans and the environment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.